M. Wachsman

The effect of systemically administered recombinant human nerve growth factor in healthy human subjects

Brent G. Petty, David R. Cornblath, Bruce T. Adornato et al. · Annals of Neurology · 1994 · 396 citations

Medicine, Neurology, Pharmacology +9

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients

K C Cundy, Brent G. Petty, John F. Flaherty et al. · Antimicrobial Agents and Chemotherapy · 1995 · 204 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +12

Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects

M. Wachsman, Brent G. Petty, K C Cundy et al. · Antiviral Research · 1996 · 95 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Protection of Guinea Pigs from Primary and Recurrent Herpes Simplex Virus (HSV) Type 2 Cutaneous Disease with Vaccinia Virus Recombinants Expressing HSV Glycoprotein D

M. Wachsman, Laure Aurelian, Cynthia C. Smith et al. · The Journal of Infectious Diseases · 1987 · 53 citations

Life Sciences, Immunology, Infectious Diseases +13

A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigs

M. Wachsman, Michael Kulka, Cynthia C. Smith et al. · Vaccine · 2001 · 45 citations

Life Sciences, Infectious Diseases, Molecular Biology +10